Yao-Chang Chen Selected Research

Trastuzumab (Herceptin)

7/2020

Trastuzumab increases pulmonary vein arrhythmogenesis through modulating pulmonary vein electrical and conduction properties via phosphatidylinositol 3-kinase signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yao-Chang Chen Research Topics

Disease

43	Atrial Fibrillation 01/2024 - 01/2004
18	Heart Failure 01/2023 - 01/2010
14	Fibrosis (Cirrhosis) 01/2024 - 01/2011
9	Inflammation (Inflammations) 01/2023 - 04/2007
8	Atrial Remodeling 01/2024 - 07/2009
8	Cardiac Arrhythmias (Arrythmia) 01/2024 - 09/2004
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2015 - 02/2003
5	Diabetes Mellitus 11/2023 - 09/2014
5	Cardiomyopathies (Cardiomyopathy) 11/2023 - 01/2016
5	Neoplasms (Cancer) 01/2018 - 05/2003
4	Tachycardia (Tachyarrhythmias) 11/2022 - 07/2009
4	Chronic Renal Insufficiency 12/2021 - 07/2017
4	Necrosis 11/2019 - 08/2010
4	Stroke (Strokes) 10/2018 - 12/2012
3	Atrial Premature Complexes (Premature Atrial Contraction) 01/2024 - 01/2020
3	Body Weight (Weight, Body) 01/2018 - 10/2011
3	Leukemia 01/2015 - 02/2003
3	Hypertension (High Blood Pressure) 01/2014 - 10/2011
2	Diabetic Cardiomyopathies 11/2023 - 01/2016
2	Ventricular Tachycardia 02/2023 - 06/2015
2	Mitochondrial Diseases (Mitochondrial Disease) 11/2022 - 11/2019
2	Pericarditis 11/2021 - 10/2018
2	Breast Neoplasms (Breast Cancer) 07/2020 - 05/2003
2	Hyponatremia 09/2019 - 03/2016
2	Infections 01/2019 - 07/2006
2	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2018 - 09/2003
2	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2016 - 09/2003
2	Atherosclerosis 05/2015 - 12/2010
2	Disease Progression 02/2015 - 02/2014
2	Multiple Myeloma 08/2014 - 09/2003
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2014 - 09/2007
2	Thrombosis (Thrombus) 12/2012 - 09/2003
2	Glioma (Gliomas) 04/2011 - 04/2010
2	Hyperthyroidism 09/2007 - 01/2002
1	Myocarditis (Carditis) 04/2024
1	Ventricular Premature Complexes (Premature Ventricular Contraction) 04/2024
1	Long QT Syndrome 02/2023
1	Sudden Death 10/2022

Drug/Important Bio-Agent (IBA)

18	CalciumIBA 11/2023 - 04/2007
6	SodiumIBA 02/2023 - 12/2011
5	CytokinesIBA 01/2024 - 04/2007
5	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2016 - 08/2010
4	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2023 - 09/2011
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2011
4	Protein Isoforms (Isoforms)IBA 01/2016 - 08/2010
3	Peptides (Polypeptides)IBA 04/2024 - 06/2012
3	Streptozocin (Streptozotocin)FDA Link 11/2023 - 01/2016
3	3- (1- benzenesulfonyl- 1H- indol- 5- yl)- N- hydroxyacrylamideIBA 10/2018 - 01/2016
3	Histone Deacetylases (Histone Deacetylase)IBA 10/2018 - 06/2016
3	Angiotensin IIIBA 12/2016 - 01/2006
3	HLA-DR Antigens (HLA-DR)IBA 01/2015 - 05/2009
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2010 - 04/2007
2	Recombinant ProteinsIBA 01/2024 - 01/2022
2	InterleukinsIBA 01/2024 - 08/2010
2	Glucagon-Like Peptide 1 (GLP 1)IBA 08/2023 - 04/2016
2	2- (2- (4- (4- nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonateIBA 02/2023 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 09/2014
2	Macrophage Migration-Inhibitory FactorsIBA 01/2023 - 01/2020
2	empagliflozinIBA 01/2023 - 04/2019
2	Advanced Glycation End ProductsIBA 11/2022 - 02/2021
2	Endothelin-1 (Endothelin 1)IBA 09/2022 - 03/2008
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2012
2	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 01/2020
2	HydrogenIBA 04/2019 - 01/2018
2	RivaroxabanIBA 10/2018 - 03/2013
2	Proteinase-Activated ReceptorsIBA 10/2018 - 12/2012
2	Factor Xa InhibitorsIBA 10/2018 - 08/2018
2	Blood Glucose (Blood Sugar)IBA 01/2018 - 01/2016
2	Ethanol (Ethyl Alcohol)IBA 01/2018 - 01/2004
2	Histone Deacetylase InhibitorsIBA 01/2018 - 01/2016
2	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 07/2017 - 12/2016
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2016 - 09/2014
2	Colchicine FDA LinkGeneric 01/2016 - 10/2014
2	Ion Channels (Ion Channel)IBA 05/2015 - 10/2014
2	Thalidomide (Thalomid)FDA Link 08/2014 - 09/2003
2	CollagenIBA 06/2013 - 01/2011
2	Rosiglitazone (Avandia)FDA Link 05/2013 - 10/2011
2	ferumoxides (Feridex)FDA Link 04/2011 - 06/2010
1	Myosins (Myosin)IBA 04/2024
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 04/2024
1	Interleukin-33IBA 01/2024
1	Glucagon-Like Peptide-1 ReceptorIBA 08/2023
1	Ranolazine FDA Link 02/2023
1	Chloroquine (Aralen)FDA LinkGeneric 02/2023
1	Azithromycin (Zithromax)FDA LinkGeneric 02/2023
1	SymportersIBA 01/2023
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2023
1	mirabegronIBA 12/2022
1	DiureticsIBA 11/2022
1	AdrenomedullinIBA 11/2022
1	LithiumIBA 10/2022
1	Dihydrotachysterol (AT 10)IBA 10/2022

Therapy/Procedure

4	Microelectrodes 11/2021 - 02/2012
3	Hematopoietic Stem Cell Transplantation 11/2016 - 09/2007
3	Ligation 01/2016 - 10/2013
3	Transplantation 11/2014 - 09/2007
3	Therapeutics 12/2011 - 07/2006
2	Subcutaneous Injections 01/2023 - 10/2018
2	Drug Therapy (Chemotherapy) 01/2004 - 02/2003
1	Ketogenic Diet 11/2023